Definium Therapeutics DFTX Earnings Call Transcripts

NASDAQ DFTX
$34.78 -0.60 (-1.71%)
As of: Nov 10, 2026 · 10:25 AM EST
4 earnings calls on file for Definium Therapeutics, from Q2 2025 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Definium Therapeutics Q1 2026 Earnings Call

May 7, 2026 7,581 words · 33 min read
  • Robert BarrowChief Executive Officer
  • Daniel KarlinChief Medical Officer
  • Brandi L. RobertsChief Financial Officer
  • Matthew WileyChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Definium Therapeutics Earnings Call Transcripts

Calls4
LatestMay 7, 2026
SinceQ2 2025

Fiscal 2026

Fiscal 2025

All 4 Definium Therapeutics transcripts Register to get access to Definium Therapeutics’s earnings call transcripts.